Providers Revert to Old Techs as German Statutory Health Insurance Halts Reimbursement for NGS Tests | GenomeWeb

This story was originally published Nov. 8.

Molecular diagnostic labs in Germany have stopped next-generation sequencing-based testing for most patients after Germany's statutory health insurance system halted reimbursement for such tests at the beginning of October.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.